Home Adaptimmune IPO Well Received By Wall Street With Plenty Of Upside Left
 

Keywords :   


Adaptimmune IPO Well Received By Wall Street With Plenty Of Upside Left

2015-05-09 12:27:58| Biotech - Topix.net

Adaptimmune Therapeutics made its initial public offering on May 6 for $17 per share. The company is a clinical trial stage biotech researching immunotherapies that use T-cell platform technology.

Tags: left street received wall

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11 3
23.11
23.11GEN FACTORY CARVE7.7 2525.5
23.11110
23.11 ssp
23.11L
23.11
23.11 DVD-BOX6
More »